HARTMANN GROUP continues sustainable growth

Focus on adding value for patients and users is paying dividends.

Heidenheim, Germany - March 28, 2017. The HARTMANN GROUP, a leading international supplier of medical and personal care products, followed up on the dynamics of the previous year with an organic growth rate of 3.3% in 2016, surpassing the benchmark set in 2015 across all segments. Taking into account negative currency effects, as well as acquisitions and divestments, consolidated sales rose by 2.3% to EUR 1,986.5 million.

EBIT climbed by 4.9% to EUR 139.1 million, while consolidated earnings after taxes improved by 6.3% to EUR 90.1 million. With a net liquidity that has more than doubled and an equity ratio of over 60%, HARTMANN GROUP can continue to invest in growth.


The HARTMANN GROUP is one of the leading European providers of professional medical and care products and associated services. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e.g. MoliCare®), Wound Care (e.g. Zetuvit®) and Infection Management (e. g. Sterillium®). This is expressed in our brand promise of “Helps. Cares. Protects.” In 2022, the HARTMANN GROUP reported Group sales of EUR 2.3 billion. Founded in 1818, the company sells its products and solutions in 130 countries around the world. For the future, the HARTMANN GROUP is currently implementing its strategic Transformation Program with its high-performance, customeroriented and passionate team.

To learn more about the HARTMANN GROUP, visit www.corporate.hartmann.info.